Peritumor Mucosa in Advanced Laryngeal Carcinoma Exhibits an Aberrant Proangiogenic Signature Distinctive from the Expression Pattern in Adjacent Tumor Tissue
Cells · 2024
DOI: 10.3390/cells13070633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Silva G Kyurkchiyan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Center, Medical University-Sofia, 1463 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, European Union.
Abstract (Originalsprache)
The field cancerization theory is an important paradigm in head and neck carcinoma as its oncological repercussions affect treatment outcomes in diverse ways. The aim of this study is to assess the possible interconnection between peritumor mucosa and the process of tumor neoangiogenesis. Sixty patients with advanced laryngeal carcinoma were enrolled in this study. The majority of patients express a canonical HIF-upregulated proangiogenic signature with almost complete predominancy of HIF-1α overexpression and normal expression levels of the HIF-2α isoform. Remarkably, more than 60% of the whole cohort also exhibited an HIF-upregulated proangiogenic signature in the peritumoral benign mucosa. Additionally, the latter subgroup had a distinctly shifted phenotype towards HIF-2α upregulation compared to the one in tumor tissue, i.e., a tendency towards an HIF switch is observed in contrast to the dominated by HIF-1α tumor phenotype. ETS-1 displays stable and identical significant overexpression in both the proangiogenic phenotypes present in tumor and peritumoral mucosa. In the current study, we report for the first time the existence of an abnormal proangiogenic expression profile present in the peritumoral mucosa in advanced laryngeal carcinoma when compared to paired distant laryngeal mucosa. Moreover, we describe a specific phenotype of this proangiogenic signature that is significantly different from the one present in tumor tissue as we delineate both phenotypes, quantitively and qualitatively. This finding is cancer heterogeneity, per se, which extends beyond the “classical” borders of the malignancy, and it is proof of a strong interconnection between field cancerization and one of the classical hallmarks of cancer—the process of tumor neoangiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Medicine Center, Medical University-Sofia, 1463 Sofia, Bulgaria.
- Department of ENT, Medical University-Sofia, 1463 Sofia, Bulgaria.
ORCID-Profile: Gergana Stancheva, Veronika Petkova, Zahari Zahariev, Radka P Kaneva, Todor M Popov
Förderung
- European Commission
- European Union
Zitieren
APA
Kyurkchiyan, S. G., Stancheva, G., Petkova, V., Panova, S., Dobriyanova, V., Stancheva, I., Marinov, V., Zahariev, Z., Kaneva, R. P., & Popov, T. M. (2024). Peritumor Mucosa in Advanced Laryngeal Carcinoma Exhibits an Aberrant Proangiogenic Signature Distinctive from the Expression Pattern in Adjacent Tumor Tissue. Cells. https://doi.org/10.3390/cells13070633
Vancouver
Kyurkchiyan SG, Stancheva G, Petkova V, Panova S, Dobriyanova V, Stancheva I, et al. Peritumor Mucosa in Advanced Laryngeal Carcinoma Exhibits an Aberrant Proangiogenic Signature Distinctive from the Expression Pattern in Adjacent Tumor Tissue. Cells. 2024. doi:10.3390/cells13070633
BibTeX
@article{Kyurkchiyan2024,
author = {Kyurkchiyan, Silva G and Stancheva, Gergana and Petkova, Veronika and Panova, Stiliana and Dobriyanova, Venera and Stancheva, Iglika and Marinov, Venelin and Zahariev, Zahari and Kaneva, Radka P and Popov, Todor M},
title = {Peritumor Mucosa in Advanced Laryngeal Carcinoma Exhibits an Aberrant Proangiogenic Signature Distinctive from the Expression Pattern in Adjacent Tumor Tissue},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13070633}
}
EUVIMED